Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001255294-12-000844
Filing Date
2012-11-19
Accepted
2012-11-19 17:24:49
Documents
12
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q 488715
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 101141
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 51798
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 8746
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 8728
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 5001
  Complete submission text file 0001255294-12-000844.txt   4593186

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ambse-20120930.xml EX-101.INS 740661
8 XBRL SCHEMA FILE ambse-20120930.xsd EX-101.SCH 70151
9 XBRL CALCULATION FILE ambse-20120930_cal.xml EX-101.CAL 31729
10 XBRL DEFINITION FILE ambse-20120930_def.xml EX-101.DEF 81850
11 XBRL LABEL FILE ambse-20120930_lab.xml EX-101.LAB 256510
12 XBRL PRESENTATION FILE ambse-20120930_pre.xml EX-101.PRE 194171
Mailing Address 675 ALMANOR AVE. SUNNYVALE CA 94085
Business Address 675 ALMANOR AVE. SUNNYVALE CA 94085 (408) 737-2734
Amarantus BioSciences, Inc. (Filer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-148922 | Film No.: 121215685
SIC: 2834 Pharmaceutical Preparations